Intergenic, gene terminal, and intragenic CpG islands in the human genome.

PubWeight™: 1.13‹?› | Rank: Top 10%

🔗 View Article (PMC 2817693)

Published in BMC Genomics on January 19, 2010

Authors

Yulia A Medvedeva1, Marina V Fridman, Nina J Oparina, Dmitry B Malko, Ekaterina O Ermakova, Ivan V Kulakovskiy, Andreas Heinzel, Vsevolod J Makeev

Author Affiliations

1: Research Institute for Genetics and Selection of Industrial Microorganisms, Genetika, 1st Dorozhny proezd, 1, Moscow, 117545, Russia. ju.medvedeva@gmail.com

Articles citing this

Cigarette smoking and DNA methylation. Front Genet (2013) 1.48

Effects of cytosine methylation on transcription factor binding sites. BMC Genomics (2014) 1.31

DNA methylation in peripheral blood measured by LUMA is associated with breast cancer in a population-based study. FASEB J (2012) 1.21

DNA methylation patterns provide insight into epigenetic regulation in the Pacific oyster (Crassostrea gigas). BMC Genomics (2010) 1.14

Promoter analysis reveals globally differential regulation of human long non-coding RNA and protein-coding genes. PLoS One (2014) 1.03

Human genetics and genomics a decade after the release of the draft sequence of the human genome. Hum Genomics (2011) 0.95

Epigenetic Silencing of ALDH1L1, a Metabolic Regulator of Cellular Proliferation, in Cancers. Genes Cancer (2011) 0.95

Epigenetic signature and enhancer activity of the human APOE gene. Hum Mol Genet (2013) 0.93

CpG island clusters and pro-epigenetic selection for CpGs in protein-coding exons of HOX and other transcription factors. Proc Natl Acad Sci U S A (2010) 0.92

DNA hypermethylation of alternatively spliced and repeat sequences in humans. Mol Genet Genomics (2012) 0.91

Epigenetic changes in the CDKN2A locus are associated with differential expression of P16INK4A and P14ARF in HPV-positive oropharyngeal squamous cell carcinoma. Cancer Med (2015) 0.86

Epigenetics and miRNA emerge as key regulators of smooth muscle cell phenotype and function. Pulm Pharmacol Ther (2012) 0.85

Dynamic DNA methylation of matrix metalloproteinase-9 in the development of diabetic retinopathy. Lab Invest (2016) 0.83

CpG islands undermethylation in human genomic regions under selective pressure. PLoS One (2011) 0.83

CpG dinucleotide frequencies reveal the role of host methylation capabilities in parvovirus evolution. J Virol (2013) 0.83

Differentially methylated loci distinguish ovarian carcinoma histological types: evaluation of a DNA methylation assay in FFPE tissue. Biomed Res Int (2013) 0.81

Ehrlichia moonlighting effectors and interkingdom interactions with the mononuclear phagocyte. Microbes Infect (2013) 0.80

The vertebrate RCAN gene family: novel insights into evolution, structure and regulation. PLoS One (2014) 0.79

CpG domains downstream of TSSs promote high levels of gene expression. Nucleic Acids Res (2014) 0.79

Abundance, arrangement, and function of sequence motifs in the chicken promoters. BMC Genomics (2014) 0.79

CpG islands under selective pressure are enriched with H3K4me3, H3K27ac and H3K36me3 histone modifications. BMC Evol Biol (2013) 0.78

Transcriptome Analysis of an Insecticide Resistant Housefly Strain: Insights about SNPs and Regulatory Elements in Cytochrome P450 Genes. PLoS One (2016) 0.77

A distinct group of CpG islands shows differential DNA methylation between replicas of the same cell line in vitro. BMC Genomics (2013) 0.76

Eicosapentaenoic acid activates RAS/ERK/C/EBPβ pathway through H-Ras intron 1 CpG island demethylation in U937 leukemia cells. PLoS One (2014) 0.76

Characterization of GPR101 transcript structure and expression patterns. J Mol Endocrinol (2016) 0.75

Genomic landscape of CpG rich elements in human. BMC Evol Biol (2017) 0.75

The Genomic Impact of DNA CpG Methylation on Gene Expression; Relationships in Prostate Cancer. Biomolecules (2017) 0.75

Preservation of methylated CpG dinucleotides in human CpG islands. Biol Direct (2016) 0.75

The Echinococcus canadensis (G7) genome: a key knowledge of parasitic platyhelminth human diseases. BMC Genomics (2017) 0.75

Articles cited by this

Initial sequencing and analysis of the human genome. Nature (2001) 212.86

A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics (2003) 82.89

WebLogo: a sequence logo generator. Genome Res (2004) 59.58

The transcriptional landscape of the mammalian genome. Science (2005) 37.63

CpG islands in vertebrate genomes. J Mol Biol (1987) 23.16

TRANSFAC and its module TRANSCompel: transcriptional gene regulation in eukaryotes. Nucleic Acids Res (2006) 22.20

DNA methylation profiling of human chromosomes 6, 20 and 22. Nat Genet (2006) 18.08

Selection of DNA binding sites by regulatory proteins. Statistical-mechanical theory and application to operators and promoters. J Mol Biol (1987) 17.53

Genome-wide analysis of mammalian promoter architecture and evolution. Nat Genet (2006) 17.19

Unbiased mapping of transcription factor binding sites along human chromosomes 21 and 22 points to widespread regulation of noncoding RNAs. Cell (2004) 16.15

Antisense transcription in the mammalian transcriptome. Science (2005) 15.69

Purification and biochemical characterization of the promoter-specific transcription factor, Sp1. Science (1986) 12.58

Comprehensive analysis of CpG islands in human chromosomes 21 and 22. Proc Natl Acad Sci U S A (2002) 12.33

A genome-wide analysis of CpG dinucleotides in the human genome distinguishes two distinct classes of promoters. Proc Natl Acad Sci U S A (2006) 10.63

DNA methylation and the frequency of CpG in animal DNA. Nucleic Acids Res (1980) 9.34

CpG islands as gene markers in the human genome. Genomics (1992) 7.45

Isolating human transcription factor targets by coupling chromatin immunoprecipitation and CpG island microarray analysis. Genes Dev (2002) 6.74

Sp1 sites in the mouse aprt gene promoter are required to prevent methylation of the CpG island. Genes Dev (1994) 4.95

Aging and DNA methylation in colorectal mucosa and cancer. Cancer Res (1998) 4.39

Purification of CpG islands using a methylated DNA binding column. Nat Genet (1994) 4.31

Mutation rates in mammalian genomes. Proc Natl Acad Sci U S A (2002) 4.23

Intergenic transcription and developmental remodeling of chromatin subdomains in the human beta-globin locus. Mol Cell (2000) 3.75

Characterization of the chicken beta-globin insulator. Proc Natl Acad Sci U S A (1997) 3.57

The CpG island searcher: a new WWW resource. In Silico Biol (2003) 3.42

A maternally methylated CpG island in KvLQT1 is associated with an antisense paternal transcript and loss of imprinting in Beckwith-Wiedemann syndrome. Proc Natl Acad Sci U S A (1999) 3.37

Sp1 transcription factor binds DNA and activates transcription even when the binding site is CpG methylated. Genes Dev (1988) 3.05

CpG island mapping by epigenome prediction. PLoS Comput Biol (2007) 3.02

Quantitative analysis of the relationship between nucleotide sequence and functional activity. Nucleic Acids Res (1986) 3.02

New methods for estimating the numbers of synonymous and nonsynonymous substitutions. J Mol Evol (1995) 2.58

A comprehensive analysis of allelic methylation status of CpG islands on human chromosome 21q. Genome Res (2004) 2.56

CAGE Basic/Analysis Databases: the CAGE resource for comprehensive promoter analysis. Nucleic Acids Res (2006) 2.54

Homotypic regulatory clusters in Drosophila. Genome Res (2003) 2.28

Mapping patterns of CpG island methylation in normal and neoplastic cells implicates both upstream and downstream regions in de novo methylation. J Biol Chem (1997) 2.27

Delta-like and gtl2 are reciprocally expressed, differentially methylated linked imprinted genes on mouse chromosome 12. Curr Biol (2000) 2.19

CpGcluster: a distance-based algorithm for CpG-island detection. BMC Bioinformatics (2006) 2.19

Determinants of CpG islands: expression in early embryo and isochore structure. Genome Res (2001) 2.07

Neutral substitutions occur at a faster rate in exons than in noncoding DNA in primate genomes. Genome Res (2003) 1.94

CpG Island microarray probe sequences derived from a physical library are representative of CpG Islands annotated on the human genome. Nucleic Acids Res (2005) 1.89

Selection in favor of nucleotides G and C diversifies evolution rates and levels of polymorphism at mammalian synonymous sites. J Theor Biol (2005) 1.88

Evolutionary anatomies of positions and types of disease-associated and neutral amino acid mutations in the human genome. BMC Genomics (2006) 1.87

DNA sequence evolution with neighbor-dependent mutation. J Comput Biol (2003) 1.76

Comprehensive identification of Drosophila dorsal-ventral patterning genes using a whole-genome tiling array. Proc Natl Acad Sci U S A (2006) 1.66

Locus control region transcription plays an active role in long-range gene activation. Mol Cell (2006) 1.63

Mechanism of transcriptional regulation by methyl-CpG binding protein MBD1. Mol Cell Biol (2000) 1.53

Rare missense and synonymous variants in UBE1 are associated with X-linked infantile spinal muscular atrophy. Am J Hum Genet (2008) 1.39

Nucleosome deposition and DNA methylation at coding region boundaries. Genome Biol (2009) 1.33

A Gibbs sampler for identification of symmetrically structured, spaced DNA motifs with improved estimation of the signal length. Bioinformatics (2005) 1.33

Epigenetic silencing mediated by CpG island methylation: potential as a therapeutic target and as a biomarker. Drug Resist Updat (2004) 1.32

CpG island density and its correlations with genomic features in mammalian genomes. Genome Biol (2008) 1.30

All and only CpG containing sequences are enriched in promoters abundantly bound by RNA polymerase II in multiple tissues. BMC Genomics (2008) 1.28

The compositional properties of human genes. J Mol Evol (1991) 1.25

Higher intensity of purifying selection on >90% of the human genes revealed by the intrinsic replacement mutation rates. Mol Biol Evol (2006) 1.12

Epigenetic boundaries of tumour suppressor gene promoters: the CTCF connection and its role in carcinogenesis. J Cell Mol Med (2006) 1.11

Exact p-value calculation for heterotypic clusters of regulatory motifs and its application in computational annotation of cis-regulatory modules. Algorithms Mol Biol (2007) 1.00

Specificity of DNA microarray hybridization: characterization, effectors and approaches for data correction. Nucleic Acids Res (2008) 0.96

Allelic expression imbalance of the human CYP3A4 gene and individual phenotypic status. Hum Mol Genet (2004) 0.92

[EDAS, databases of alternatively spliced human genes]. Biofizika (2006) 0.86

A comprehensive catalog of CpG islands methylated in human lung adenocarcinomas for the identification of tumor suppressor genes. Oncogene (2002) 0.85

Articles by these authors

Assessing computational tools for the discovery of transcription factor binding sites. Nat Biotechnol (2005) 14.29

A promoter-level mammalian expression atlas. Nature (2014) 6.25

Homotypic regulatory clusters in Drosophila. Genome Res (2003) 2.28

Exploring massive, genome scale datasets with the GenometriCorr package. PLoS Comput Biol (2012) 1.89

Extraction of functional binding sites from unique regulatory regions: the Drosophila early developmental enhancers. Genome Res (2002) 1.82

De novo sequencing and characterization of floral transcriptome in two species of buckwheat (Fagopyrum). BMC Genomics (2011) 1.62

HOCOMOCO: a comprehensive collection of human transcription factor binding sites models. Nucleic Acids Res (2012) 1.45

Effects of cytosine methylation on transcription factor binding sites. BMC Genomics (2014) 1.31

Motif discovery and motif finding from genome-mapped DNase footprint data. Bioinformatics (2009) 1.15

Evolution of exon-intron structure and alternative splicing in fruit flies and malarial mosquito genomes. Genome Res (2006) 1.13

In vitro selection of optimal RelB/p52 DNA-binding motifs. Biochem Biophys Res Commun (2007) 1.08

Genomic reconstruction of the transcriptional regulatory network in Bacillus subtilis. J Bacteriol (2013) 1.03

Exact p-value calculation for heterotypic clusters of regulatory motifs and its application in computational annotation of cis-regulatory modules. Algorithms Mol Biol (2007) 1.00

The complete genome sequence of Pantoea ananatis AJ13355, an organism with great biotechnological potential. Appl Microbiol Biotechnol (2011) 0.94

Concept and application of a computational vaccinology workflow. Immunome Res (2010) 0.93

Mapping of molecular pathways, biomarkers and drug targets for diabetic nephropathy. Proteomics Clin Appl (2011) 0.90

Evolution of transcription factor DNA binding sites. Gene (2005) 0.89

Application of experimentally verified transcription factor binding sites models for computational analysis of ChIP-Seq data. BMC Genomics (2014) 0.88

Analysis of functional importance of binding sites in the Drosophila gap gene network model. BMC Genomics (2015) 0.87

CORECLUST: identification of the conserved CRM grammar together with prediction of gene regulation. Nucleic Acids Res (2012) 0.82

DNA sequence motif: a jack of all trades for ChIP-Seq data. Adv Protein Chem Struct Biol (2013) 0.81

Plasma proteomics classifiers improve risk prediction for renal disease in patients with hypertension or type 2 diabetes. J Hypertens (2015) 0.78

Atomic hydration potentials using a Monte Carlo Reference State (MCRS) for protein solvation modeling. BMC Struct Biol (2007) 0.76

Complete Genome Sequence of Bifidobacterium longum GT15: Unique Genes for Russian Strains. Genome Announc (2014) 0.75

Identification of self-consistent modulons from bacterial microarray expression data with the help of structured regulon gene sets. J Biomol Struct Dyn (2012) 0.75

A model of evolution with constant selective pressure for regulatory DNA sites. BMC Evol Biol (2007) 0.75

Synthetic lethality for linking the mycophenolate mofetil mode of action with molecular disease and drug profiles. Mol Biosyst (2012) 0.75

Predictive biology using systems and integrative analysis and methods. J Biomol Struct Dyn (2013) 0.75

The channel in transporters is formed by residues that are rare in transmembrane helices. In Silico Biol (2003) 0.75

Predictive biomarkers for linking disease pathology and drug effect. Curr Pharm Des (2016) 0.75